Abintus Bio, Inc. is a San Diego-based, preclinical stage gene therapy company focused on the discovery and development of a portfolio of product candidates that are designed to directly reprogram immune cells from within their native environment, using proprietary vectors and related technologies.
Currently, there are no issues on this topic.